Protocol No.: A011-16

Title
A Phase 2, Double-blind, Randomized, Placebo controlled Study to Evaluate the Effects of Sotatercept versus Placebo for the Treatment of Combined Postcapillary and Precapillary Pulmonary Hypertension (Cpc-PH) due to Heart Failure with Preserved Ejection Fraction (HFpEF)
Principal Investigator
Caccamo, Marco
Phase
II
Age Group
Adult
Applicable Disease Site
Heart/Cardiovascular Disease
Participating Institutions
Heart & Vascular Institute
West Virginia University
Contacts

View on ClinicalTrials.gov